Free Trial

aTyr Pharma (LIFE) Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Earnings Summary

Upcoming
Earnings Date
Aug. 14Estimated
Actual EPS
(May. 2)
-$0.23 Beat By $0.01
Consensus EPS
(May. 2)
-$0.24
Skip Charts & View Estimated and Actual Earnings Data

LIFE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LIFE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

aTyr Pharma Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.89) EPS
Next Year EPS Consensus Estimate: ($0.74) EPS

LIFE Earnings Date and Information

aTyr Pharma last issued its earnings data on May 2nd, 2024. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.24) by $0.01. The business earned $0.24 million during the quarter, compared to the consensus estimate of $0.11 million. aTyr Pharma has generated ($0.90) earnings per share over the last year (($0.90) diluted earnings per share). Earnings for aTyr Pharma are expected to grow in the coming year, from ($0.89) to ($0.74) per share. aTyr Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.

aTyr Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/14/2024
(Estimated)
------- 
5/2/2024Q1 2024($0.24)($0.23)+$0.01($0.23)$0.11 million$0.24 million  
3/14/2024Q4 2023($0.23)($0.25)($0.02)($0.25)--
11/9/2023Q3 2023($0.21)($0.20)+$0.01($0.20)$6.00 million$0.35 million
8/9/2023Q2 2023($0.27)($0.22)+$0.05($0.22)--
5/9/2023Q1 2023($0.39)($0.29)+$0.10($0.29)--
3/9/2023Q4 2022($0.48)($0.26)+$0.22($0.26)$1.50 million$10.39 million
11/10/2022Q3 2022($0.45)($0.46)($0.01)($0.46)--
8/15/2022Q2 2022($0.43)($0.44)($0.01)($0.44)--    
5/9/2022Q1 2022($0.34)($0.44)($0.10)($0.44)--    
3/14/2022Q4 2021($0.24)($0.31)($0.07)($0.31)--    
11/10/2021Q3 2021($0.53)($0.42)+$0.11($0.42)--    
8/9/2021Q2 2021($0.51)($0.64)($0.13)($0.64)--    
5/13/2021Q1 2021($0.34)($0.51)($0.17)($0.51)--  
3/22/2021Q4 2020($0.82)($0.47)+$0.35($0.47)$0.13 million$2.05 million  
11/17/2020Q3 2020($0.74)($0.68)+$0.06($0.68)$0.16 million$0.15 million  
8/13/2020Q2 2020($0.73)($0.69)+$0.04($0.69)$0.40 million$0.19 million  
5/12/2020Q1 2020($0.18)$0.25+$0.43$0.25$4.40 million$8.07 million  
3/26/2020Q4 2019($1.59)($1.54)+$0.05($1.54)$0.09 million$0.14 million  
11/14/2019Q3 2019($1.43)($1.47)($0.04)($1.47)$0.06 million$0.18 million  
8/14/2019Q2 2019($2.74)($1.80)+$0.94($1.80)-$0.09 million

aTyr Pharma Earnings - Frequently Asked Questions

When is aTyr Pharma's earnings date?

aTyr Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on LIFE's earnings history.

Did aTyr Pharma beat their earnings estimates last quarter?

In the previous quarter, aTyr Pharma (NASDAQ:LIFE) reported ($0.23) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.24) by $0.01. Learn more on analysts' earnings estimate vs. LIFE's actual earnings.

How can I read aTyr Pharma's conference call transcript?

The conference call transcript for aTyr Pharma's latest earnings report can be read online. Read Transcript

How much revenue does aTyr Pharma generate each year?

aTyr Pharma (NASDAQ:LIFE) has a recorded annual revenue of $350,000.00.

How much profit does aTyr Pharma generate each year?

aTyr Pharma (NASDAQ:LIFE) has a recorded net income of -$50.39 million. LIFE has generated -$0.90 earnings per share over the last four quarters.

What is aTyr Pharma's EPS forecast for next year?

aTyr Pharma's earnings are expected to grow from ($0.89) per share to ($0.74) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:LIFE) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners